These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18844328)

  • 1. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial.
    Mori K; Inatomi S; Ouchi K; Azumi Y; Tuchida T
    Phytother Res; 2009 Mar; 23(3):367-72. PubMed ID: 18844328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing effect of HT008-1 on cognitive function and quality of life in cognitively declined healthy adults: a randomized, double-blind, placebo-controlled, trial.
    Kim J; Chung SY; Park S; Park JH; Byun S; Hwang M; Oh DS; Choi H; Kim MY; Bu YC; Doré S; Whang WW; Kim H
    Pharmacol Biochem Behav; 2008 Oct; 90(4):517-24. PubMed ID: 18550156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
    Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
    Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
    Schifitto G; Navia BA; Yiannoutsos CT; Marra CM; Chang L; Ernst T; Jarvik JG; Miller EN; Singer EJ; Ellis RJ; Kolson DL; Simpson D; Nath A; Berger J; Shriver SL; Millar LL; Colquhoun D; Lenkinski R; Gonzalez RG; Lipton SA; ; ;
    AIDS; 2007 Sep; 21(14):1877-86. PubMed ID: 17721095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial.
    van Uffelen JG; Chinapaw MJ; van Mechelen W; Hopman-Rock M
    Br J Sports Med; 2008 May; 42(5):344-51. PubMed ID: 18308888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in muscle endurance in mice by dietary Yamabushitake mushroom (Hericium erinaceus) possibly via activation of PPARδ.
    Komiya Y; Nakamura T; Ishii M; Shimizu K; Hiraki E; Kawabata F; Nakamura M; Tatsumi R; Ikeuchi Y; Mizunoya W
    Anim Sci J; 2019 Jun; 90(6):781-789. PubMed ID: 30938015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study.
    Gómez-Isla T; Blesa R; Boada M; Clarimón J; Del Ser T; Domenech G; Ferro JM; Gómez-Ansón B; Manubens JM; Martínez-Lage JM; Muñoz D; Peña-Casanova J; Torres F;
    Alzheimer Dis Assoc Disord; 2008; 22(1):21-9. PubMed ID: 18317243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
    Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study on a randomized, double-blind control of Shenwu gelatin capsule in treatment of mild cognitive impairment].
    Zhong J; Tian JZ; Zhu AH; Yang CZ
    Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(17):1800-3. PubMed ID: 17993008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
    Stough C; Downey LA; Lloyd J; Silber B; Redman S; Hutchison C; Wesnes K; Nathan PJ
    Phytother Res; 2008 Dec; 22(12):1629-34. PubMed ID: 18683852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of estrogen treatment in men with mild cognitive impairment.
    Sherwin BB; Chertkow H; Schipper H; Nasreddine Z
    Neurobiol Aging; 2011 Oct; 32(10):1808-17. PubMed ID: 20004499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese herbal medicine for Mild Cognitive Impairment and Age Associated Memory Impairment: a review of randomised controlled trials.
    May BH; Yang AW; Zhang AL; Owens MD; Bennett L; Head R; Cobiac L; Li CG; Hugel H; Story DF; Xue CC
    Biogerontology; 2009 Apr; 10(2):109-23. PubMed ID: 18716893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of cognitive functions by oral intake of Hericium erinaceus.
    Saitsu Y; Nishide A; Kikushima K; Shimizu K; Ohnuki K
    Biomed Res; 2019; 40(4):125-131. PubMed ID: 31413233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of oxiracetam therapy in the treatment of cognitive deficiencies secondary to primary degenerative dementia.
    Rozzini R; Zanetti O; Bianchetti A
    Acta Neurol (Napoli); 1992 Apr; 14(2):117-26. PubMed ID: 1414555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Liu G; Weinger JG; Lu ZL; Xue F; Sadeghpour S
    J Alzheimers Dis; 2016; 49(4):971-90. PubMed ID: 26519439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial.
    Akural EI; Järvimäki V; Länsineva A; Niinimaa A; Alahuhta S
    Clin Ther; 2009 Mar; 31(3):560-8. PubMed ID: 19393845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients.
    Kemény V; Molnár S; Andrejkovics M; Makai A; Csiba L
    J Clin Pharmacol; 2005 Sep; 45(9):1048-54. PubMed ID: 16100299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.